Freedom Anti-Inflammation ETS Softgels®
€54,50
180 softgels. 2 month supply

◼ TAME THE FLAME
◼ Easy-to-Swallow Softgels®
◼ Clinically tested and designed to quell the insidious flames of destructive, silent inflammation.
◼ Freedom Anti-Inflammation ETS Softgels® help to relieve:
– Chronic Muscle Pain
– Joint Discomfort
– Systemic Inflammation


Q10 and Vitamin Supplements for Europe
Out of stock
Description
Freedom Anti-Inflammation ETS Softgels® summary
The function of Freedom Anti-Inflammation ETS Softgels® is to free you from the underlying causes of all that ails you. Chronic inflammation is both a symptom and a cause of many long-term diseases. Freedom Softgels® presents an appealing remedy that consumers can rely on without the concerns caused by long-term use of steroids and non-steroidal anti-inflammatory drugs (NSAIDs). Freedom Softgels® are a ground-breaking product showing statistically significant results in a short period of time. The benefits will appeal to people with a broad range of health concerns.
◼ A comprehensive, proprietary formula combining the highest quality branded, proprietary, patented ingredients whose integrated benefits far exceed the sum of their parts.
◼ Every ingredient is “the star ingredient”—each one a stand-out in its “field”, hand-selected for purity, potency, and optimal bioavailability and bioefficiency.
◼ clinically proven to fight inflammation and improve cardiovascular health in just 28 days:
– Lowers CRP and IL-6
– Lowers blood pressure to normal range
– Improves the elasticity of the blood vessels
– Significant increase in omega-3 index
◼ A second 90 day RCT gold standard study is underway
◼ Clinically proven Freedom Anti-Inflammation ETS Softgels® are new in Europe and promoted on nutraceutical exhibitions and in European Nutraceuticals Now magazine
Freedom Anti-Inflammation ETS Softgels® GMP quality
Manufactured in a cGMP Certified USA Facility by:
Gel-Tec, Division of Tishcon Corp.
30 New York Ave, Westbury, NY 11590 USA
www.tishcon.com
Reviews
There are no reviews yet.